麝香酮经抑制TRAF6介导信号通路改善去卵巢骨丢失与破骨细胞生成
本文研究麝香酮对去卵巢(OVX)小鼠骨丢失及RANKL诱导破骨细胞生成的作用机制。体外实验显示麝香酮抑制TRAF6与RANK结合,阻断NF-κB和MAPK通路及下游标志物表达;体内实验表明麝香酮减少OVX小鼠骨丢失。
要点
- 麝香酮抑制RANKL诱导的破骨细胞分化与功能。
- 麝香酮通过阻断TRAF6与RANK结合抑制NF-κB和MAPK通路。
- 麝香酮减少OVX小鼠骨丢失并降低TNF-a和IL-6水平。
核心结论
- 麝香酮通过抑制TRAF6与RANK结合阻断NF-κB和MAPK通路,抑制破骨细胞生成与功能,并减少去卵巢诱导的小鼠骨丢失。
研究设计与样本
- 体外研究进行破骨细胞生成形态学检测,并用RT-PCR和Western blot检测RANK诱导的NF-κB和MAPK通路因子,共免疫沉淀和免疫荧光检测TRAF6与RANK结合。
- 体内实验使用C57BL/6去卵巢(OVX)小鼠,进行H&E染色、TRAP染色和micro CT检测。
主要发现
- 麝香酮减少OVX小鼠骨丢失并抑制体外破骨细胞分化。
- 麝香酮抑制TRAF6与RANK结合,进而抑制NF-κB和MAPK信号通路。
- 麝香酮抑制下游标志物NFATc1、CTR、TRAP、cathepsin K和MMP-9表达。
- 麝香酮降低炎症因子TNF-a和IL-6水平。
临床怎么用
- 麝香酮的抗炎与抑制破骨细胞生成作用提示其可能用于绝经后骨质疏松的辅助干预,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Postmenopausal osteoporosis is caused by the deficiency of estrogen, which breaks bone homeostasis and induces levels of pro-inflammatory cytokines. Muscone is a potent anti-inflammatory agent and is used to treat bone fracture in traditional Chinese medicine. However, its anti-osteoclastogenic effects remain unclear. For in vitro study, morphology tests of osteoclastogenesis were firstly performed. And then, factors in RANK-induced NF-κB and MAPK pathways were examined by RT-PCR and Western blot, and the binding of TNF receptor-associated factor (TRAF)6 to RANK was inspected by coimmunoprecipitation and immunofluorescence staining. For in vivo experiments, C57BL/6 ovariectomized (OVX) mice were used for detection, including H&E staining, TRAP staining, and micro CT. As a result, muscone reduced OVX-induced bone loss in mice and osteoclast differentiation in vitro, by inhibiting TRAF6 binding to RANK, and then suppressed NF-κB and MAPK signaling pathways. The expression of the downstream biomarkers was finally inhibited, including NFATc1, CTR, TRAP, cathepsin K, and MMP-9. The inflammatory factors, TNF-a and IL-6, were also reduced by muscone. Taken together, muscone inhibited the binding of TRAF6 to RANK induced by RANKL, thus blocking NF-kB and MAPK pathways, and down-regulating related gene expression. Finally, muscone inhibited osteoclastogenesis and osteoclast function by blocking RANK-TRAF6 binding, as well as downstream signaling pathways in vitro. Muscone also reduced ovariectomy-induced bone loss in vivo.
引用
- Zhai X, Yan Z, Zhao J, et al. Muscone Ameliorates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-κb Ligand-Induced Osteoclastogenesis by Suppressing TNF Receptor-Associated Factor 6-Mediated Signaling Pathways. Front Pharmacol. 2020. PMID: 32265718. doi:10.3389/fphar.2020.00348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。